Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China.


Journal

Journal of infection in developing countries
ISSN: 1972-2680
Titre abrégé: J Infect Dev Ctries
Pays: Italy
ID NLM: 101305410

Informations de publication

Date de publication:
29 02 2020
Historique:
received: 28 02 2020
accepted: 29 02 2020
entrez: 9 3 2020
pubmed: 9 3 2020
medline: 19 3 2020
Statut: epublish

Résumé

As of 28 February 2020, Italy had 888 cases of SARS-CoV-2 infections, with most cases in Northern Italy in the Lombardia and Veneto regions. Travel-related cases were the main source of COVID-19 cases during the early stages of the current epidemic in Italy. The month of February, however, has been dominated by two large clusters of outbreaks in Northern Italy, south of Milan, with mainly local transmission the source of infections. Contact tracing has failed to identify patient zero in one of the outbreaks. As of 28 February 2020, twenty-one cases of COVID-19 have died. Comparison between case fatality rates in China and Italy are identical at 2.3. Additionally, deaths are similar in both countries with fatalities in mostly the elderly with known comorbidities. It will be important to develop point-of-care devices to aid clinicians in stratifying elderly patients as early as possible to determine the potential level of care they will require to improve their chances of survival from COVID-19 disease.

Identifiants

pubmed: 32146445
doi: 10.3855/jidc.12600
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

125-128

Informations de copyright

Copyright (c) 2020 Rossella Porcheddu, Caterina Serra, David Kelvin, Nikki Kelvin, Salvatore Rubino.

Déclaration de conflit d'intérêts

No Conflict of Interest is declared

Auteurs

Rossella Porcheddu (R)

Freelance Journalist, JIDC Italy. rporcheddu@jidc.org.

Caterina Serra (C)

Dipartimento di Scienze Biomediche, Università degli Studi di Sassari, Sassari, Italy. cserra@uniss.it.

David Kelvin (D)

JIDC-Canada; Department of Microbiology and Immunology, Canadian Center for Vaccinology, Dalhousie University, Halifax, NS, Canada. International Institute of Infection and Immunity, Shantou, China. dkelvin@jidc.org.

Nikki Kelvin (N)

JIDC-Canada, Department of Microbiology and Immunology, Dalhousie University, Halifax, NS, Canada. nkelvin@jidc.org.

Salvatore Rubino (S)

Dipartimento di Scienze Biomediche, Università degli Studi di Sassari, Sassari, Italy. srubino@jidc.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH